Clinical Trial Update: Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses joint outcomes in subjects with severe Hemophilia A across different treatment regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED